|
 |
CapromabThis page contains recent news articles, when available, and an overview of Capromab but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Capromab (when available) Binds to the prostate-specific membrane antigen, which is a cell surface protein generally overexpressed in prostate tissues and prostate cancers. The radioactive Indium 111, which is covalently attached to the antibody, allows radiodiagnostic detection of PSMA expressing cells and tumors For diagnosis of prostate cancer and detection of intra-pelvic metastases Mechanism Of Action: Binds selectively to cell-surface prostate-specific membrane antigen (PSMA) expressed on prostate tissues and tumors. News Articles on Capromab 2008-07-02 21:13:17 - www.companiesandmarkets.com adds new report ... - 03 Jul 2008 The company currently markets Quadramet (samarium Sm-153 lexidronam injection), Prostascint (capromab pendetide), and Soltamox (tamoxifen citrate) to the US PR-Inside.com (Pressemitteilung), Cytogen Reports First Quarter 2008 Financial Results - May 8, 2008 PROSTASCINT(R) (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer. PharmaLive.com (press release), BUYINS.NET: WRE, NUJ, AKNS, BLTI, CYTO, JRJC Have Also Been ... - Apr 2, 2008 It markets QUADRAMET (samarium Sm-153 lexidronam injection), PROSTASCINT (capromab pendetide), and SOLTAMOX (tamoxifen citrate) to the United States Trading Markets (press release), Cytogen Announces Quarterly Conference Call and Presentation at ... - Oct 25, 2007 PROSTASCINT® (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer and SOLTAMOX™ WELT ONLINE, BUYINS.NET: GDP, ADG, GMO, CYTO, TRLG, SWTS Have Been Removed From ... - Oct 29, 2007 It markets QUADRAMET (samarium Sm-153 lexidronam injection), PROSTASCINT (capromab pendetide), and SOLTAMOX (tamoxifen citrate) to the United States Trading Markets (press release), Cytogen to Present at the BIO Investor Forum 2007 - Oct 3, 2007 PROSTASCINT(R) (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer and SOLTAMOX(TM) PharmaLive.com (press release), ROTH 2007 New York Conference Presenter Profiles - Sep 4, 2007 PROSTASCINT(R) (capromab pendetide) is a PSMA-targeting monoclonal antibody-based imaging agent for prostate cancer and SOLTAMOX(TM) (tamoxifen citrate) is TMC Net, Cytogen Reports Second Quarter 2007 Financial Results - Aug 8, 2007 PROSTASCINT(R) (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer and SOLTAMOX(TM) Genetic Engineering News (press release), Cytogen to Raise $10.1 Million through Private Placement of Common ... - Jun 29, 2007 Business Wire (press release),PROSTASCINT ® (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer and SOLTAMOX™ Outcomes Data Continue to Demonstrate Value of Cytogen’s ... - May 22, 2007 Business Wire (press release),PROSTASCINT ® (capromab pendetide) is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer and SOLTAMOX Cytogen Reports First Quarter 2007 Financial Results - May 10, 2007 PharmaLive.com (press release),Cytogen's product revenues were comprised of sales of QUADRAMET(R) (samarium Sm-153 lexidronam injection) and PROSTASCINT(R) (capromab pendetide). Expanded Role for Cytogen's PROSTASCINT(R) Incorporated Into NCCN ... - Jan 4, 2007 American Digital Networks (press release),Cancer Network (NCCN) has included PROSTASCINT(R) (capromab pendetide) in its updated clinical practice guidelines for recurrent prostate cancer. Expanded Role for Cytogen's PROSTASCINT(R) Incorporated Into NCCN ... - Jan 4, 2007 Genetic Engineering News (press release),Cytogen Corporation (NASDAQ: CYTO) today reported that the National Comprehensive Cancer Network (NCCN) has included PROSTASCINT(R) (capromab pendetide) in Combination of High Dose QUADRAMET(R) and Chemotherapy Shows ... Sep 18, 2006 Cytogen's marketed products include QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide) kit for the preparation of Indium In ... -Yahoo! News Cancer Patients Show Reduced Pain And Lower Analgesic Consumption ... Sep 20, 2006 Cytogen's marketed products include QUADRAMET(R) (samarium Sm-153 lexidronam injection), PROSTASCINT(R) (capromab pendetide) kit for the preparation of Indium ... -Medical News Today Cytogen Corporation and Mayor Rudy Giuliani to Ring in Prostate ... 29 Aug 2006 Cytogen's marketed products include QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide) kit for the preparation of Indium In ... -Yahoo! News Cytogen Announces FDA Clears IND For CYT-500, A Monoclonal ... May 9, 2006 CYT-500 uses the same monoclonal antibody from Cytogen's PROSTASCINT(R) (capromab pendetide) molecular imaging agent, but is linked through a higher affinity ... - Medical News Today Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 ... May 11, 2006 Cytogen's marketed products include QUADRAMET(R) (samarium Sm-153 lexidronam injection), PROSTASCINT(R) (capromab pendetide) kit for the preparation of Indium ... - Genetic Engineering News Cytogen Corporation to Present at the Rodman & Renshaw 3rd Annual ... May 9, 2006 Cytogen's marketed products include QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide) kit for the preparation of Indium In ... - Yahoo! News Cytogen Reports First Quarter 2006 Financial Results May 8, 2006 ...and is currently available on the AUA website at http://www.auanet.org, which is not part of this press release: -- "SPECT/CT Capromab Pendetide Independently ... - Yahoo! News Cytogen antibody gets FDA trial OK May 9, 2006 CYT-500 uses the same monoclonal antibody from Cytogen's Prostascint (capromab pendetide) molecular imaging agent, but is linked through a higher affinity ... - Pharmaceutical Business Review Cytogen Sells Ownership in PSMA Development Joint Venture to ... Apr 24, 2006 CYT-500 incorporates the same monoclonal antibody utilized in Cytogen's PROSTASCINT® (capromab pendetide) molecular imaging agent, but is linked to a ... - Yahoo! News Cytogen tests antibody for prostate cancer May 8, 2006 The company said the treatment incorporates the same monoclonal antibody as that used in Cytogen's Prostascint (capromab pendetide) molecular imaging agent and ... - United Press International Cytogen Selling PSMA Joint Venture Share To Progenics Apr 24, 2006 It incorporates the same monoclonal antibody used in Cytogen's Prostascint (capromab pendetide) molecular imaging agent, but is linked to a therapeutic as ... - BioWorld Online (subscription) Cytogen Announces Submission of IND for CYT-500 for the Treatment ... Apr 6, 2006 CYT-500 incorporates the same monoclonal antibody utilized in Cytogen's PROSTASCINT® (capromab pendetide) molecular imaging agent, but is linked to a ... - Yahoo! News New Study Shows QUADRAMET(R) May Enhance Immune System Recognition ... Apr 4, 2006 Cytogen's marketed products include QUADRAMET® (samarium Sm-153 lexidronam injection) and PROSTASCINT® (capromab pendetide) kit for the preparation of Indium ... - Yahoo! News Cytogen Announces Schedule for Clinical Data Presentations at ... Mar 23, 2006 The company also announced that clinical data from a recent study involving its second marketed product, PROSTASCINT(R) (capromab pendetide), will be presented ... - PR Newswire Positive Findings From Clinical Studies of QUADRAMET(R) in ... Feb 27, 2006 Cytogen's marketed products include QUADRAMET(R) (samarium Sm-153 lexidronam injection) and PROSTASCINT(R) (capromab pendetide) kit for the preparation of ... - International News Service, Brand Names/Synonyms: Capromab is also known by the following brand names and/or synonymsProstaScint; ProstaScint (Cytogen Corp) Drug Category: Capromab is categorized under the following by the FDA: Imaging Agents Dosage Forms: Not Available Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Murine anti-7E11 antibody : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |